Investments
19Portfolio Exits
7Funds
4Latest GL Capital News
Nov 5, 2021
All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.
GL Capital Investments
19 Investments
GL Capital has made 19 investments. Their latest investment was in Leateck as part of their Series A on January 1, 2022.
GL Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/17/2022 | Series A | Leateck | Yes | 1 | ||
11/5/2021 | Series C | Hzymes Biotech | $124.97M | Yes | 4 | |
8/26/2021 | Series B | Desano Pharma | Yes | GT Capital, Jiading Venture Capital, Kangcheng Investment, New Alliance Capital, Runxin New Vision Industry Fund, and Shenzhen Capital Group | 1 | |
7/26/2021 | Private Equity - II | |||||
6/15/2021 | Series C |
Date | 1/17/2022 | 11/5/2021 | 8/26/2021 | 7/26/2021 | 6/15/2021 |
|---|---|---|---|---|---|
Round | Series A | Series C | Series B | Private Equity - II | Series C |
Company | Leateck | Hzymes Biotech | Desano Pharma | ||
Amount | $124.97M | ||||
New? | Yes | Yes | Yes | ||
Co-Investors | GT Capital, Jiading Venture Capital, Kangcheng Investment, New Alliance Capital, Runxin New Vision Industry Fund, and Shenzhen Capital Group | ||||
Sources | 1 | 4 | 1 |
GL Capital Portfolio Exits
7 Portfolio Exits
GL Capital has 7 portfolio exits. Their latest portfolio exit was Arrail Dental on March 22, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/22/2022 | IPO | 2 | |||
Date | 3/22/2022 | ||||
|---|---|---|---|---|---|
Exit | IPO | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 |
GL Capital Acquisitions
2 Acquisitions
GL Capital acquired 2 companies. Their latest acquisition was SciClone Pharmaceuticals on October 13, 2017.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
10/13/2017 | Take Private | 3 | ||||
3/15/2017 |
Date | 10/13/2017 | 3/15/2017 |
|---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Take Private | |
Sources | 3 |
GL Capital Fund History
4 Fund Histories
GL Capital has 4 funds, including GL China Opportunities Fund II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/31/2016 | GL China Opportunities Fund II | Expansions & Growth | Closed | $870M | 1 |
12/31/2009 | GL Capital Fund | ||||
GL China Opportunities Fund III LP | |||||
GL YARD INVESTMENT L.P. |
Closing Date | 12/31/2016 | 12/31/2009 | ||
|---|---|---|---|---|
Fund | GL China Opportunities Fund II | GL Capital Fund | GL China Opportunities Fund III LP | GL YARD INVESTMENT L.P. |
Fund Type | Expansions & Growth | |||
Status | Closed | |||
Amount | $870M | |||
Sources | 1 |
GL Capital Team
1 Team Member
GL Capital has 1 team member, including current Founding Partner, Zhenfu Li.
Name | Work History | Title | Status |
|---|---|---|---|
Zhenfu Li | Founding Partner | Current |
Name | Zhenfu Li |
|---|---|
Work History | |
Title | Founding Partner |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.